.jpg/jcr:content.jpg)
Welkom op Campus Sanofi
Heeft u al een account bij Campus Sanofi? Registreer om gepersonaliseerde berichten te ontvangen.
Artikelen
Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).
When to treat
Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2
Renal involvement in Fabry disease
Think Fabry, think renal involvement that may present early in life and could go undetected.
Cardiac involvement in Fabry disease
Cardiovascular disease is the leading cause of death in Fabry disease patients.1 Undiagnosed and untreated Fabry disease leads to progressive, irreversible, life-threatening heart injury.2,3
Educatie
Polyp Gossip Episode 5: Personalized Care for CRSwNP: Finding What Works Best for You
In this episode of Polyp Gossip, we explore the power of personalized care in CRSwNP. From symptoms to patient profiles, our experts discuss how tailored treatment strategies can lead to better outcomes and improved quality of life. Tune in to discover what "finding what works best for you" really means in today's evolving care landscape.
Bevestig uw status
Bevestig uw status
Sanofi biedt u exclusieve content over onze verschillende therapeutische gebieden op één portal
speciaal voor professionals in de gezondheidszorg, inclusief wetenschappelijk nieuws, een ljst met
evenementen en tools en diensten voor uw dagelijkse praktik.